Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing
Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19
Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392